Operating Lease, Right-of-Use Asset of Connect Biopharma Holdings Ltd from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Connect Biopharma Holdings Ltd quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
Connect Biopharma Holdings Ltd Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $737,000.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Connect Biopharma Holdings Ltd Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$737,000			30 Sep 2025	10-Q	12 Nov 2025	2025	Q3
Q2 2025	$825,000			30 Jun 2025	10-Q	13 Aug 2025	2025	Q2
Q1 2025	$928,000			31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q4 2024	$189,000	-$273,000	-59%	31 Dec 2024	10-Q	12 Nov 2025	2025	Q3
Q4 2023	$462,000			31 Dec 2023	10-K	31 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.